Ketamine Revisited - New Insights into NMDA Inhibitors

*Edited by Nieves Saiz-Sapena and Manuel Granell-Gil*

Published in London, United Kingdom

## *Supporting open minds since 2005*

Ketamine Revisited - New Insights into NMDA Inhibitors http://dx.doi.org/10.5772/intechopen.95733 Edited by Nieves Saiz-Sapena and Manuel Granell-Gil

#### Contributors

Shridevi Pandya Shah, Antony Irungu, Devanshi Patel, Tahani K. Alshammari, Sarah Alseraye, Nouf M. Alrasheed, Anfal F. Bin Dayel, Asma S. Alonazi, Jawza F. Al Sabhan, Musaad A. Alshammari, Maiko Satomoto, Cigdem Yildirim Guclu, Preet Mohinder Singh Bedi, Atamjit Singh, Guochuan Emil Tsai, Chih-Hung Lin, Po-Chang Shih, Shahla Haleem, Mateja Lopuh, Bhagyalakshmi Ramesh, Carlos Rafael Ramirez-Paesano, Claudia Rodiera Clarens, María Martínez Alberici, José Carlos Torres Mandujano, Milen Bonev Bonev, Florencia Borghetti, Karen Salazar Loaiza, Josep Rodiera Olive, Jesus Santaliestra Fierro, Bhargab Deka, Biswajit Dash, Alakesh Bharali, Ashique Ahmed, Chimaobi Tim Nnaji, Arunas Gelmanas, Migle Vitartaite, Ramunas Tamosiunas, Andrius Macas, Patrycja Kleczkowska, Malgorzata Zaremba, Mihai Octavian Botea, Erika Bimbo-Szuhai, Subbulakshmi Sundaram, Ashok Swaminathan Govindarajan, Molotchnikoff Stephane, Ouelhazi Afef, Rudy Lussiez, Nieves Saiz-Sapena, Manuel Granell-Gil

#### © The Editor(s) and the Author(s) 2022

The rights of the editor(s) and the author(s) have been asserted in accordance with the Copyright, Designs and Patents Act 1988. All rights to the book as a whole are reserved by INTECHOPEN LIMITED. The book as a whole (compilation) cannot be reproduced, distributed or used for commercial or non-commercial purposes without INTECHOPEN LIMITED's written permission. Enquiries concerning the use of the book should be directed to INTECHOPEN LIMITED rights and permissions department (permissions@intechopen.com).

Violations are liable to prosecution under the governing Copyright Law.

Individual chapters of this publication are distributed under the terms of the Creative Commons Attribution 3.0 Unported License which permits commercial use, distribution and reproduction of the individual chapters, provided the original author(s) and source publication are appropriately acknowledged. If so indicated, certain images may not be included under the Creative Commons license. In such cases users will need to obtain permission from the license holder to reproduce the material. More details and guidelines concerning content reuse and adaptation can be found at http://www.intechopen.com/copyright-policy.html.

#### Notice

Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book.

First published in London, United Kingdom, 2022 by IntechOpen IntechOpen is the global imprint of INTECHOPEN LIMITED, registered in England and Wales, registration number: 11086078, 5 Princes Gate Court, London, SW7 2QJ, United Kingdom Printed in Croatia

British Library Cataloguing-in-Publication Data A catalogue record for this book is available from the British Library

Additional hard and PDF copies can be obtained from orders@intechopen.com

Ketamine Revisited - New Insights into NMDA Inhibitors Edited by Nieves Saiz-Sapena and Manuel Granell-Gil p. cm. Print ISBN 978-1-83962-792-7 Online ISBN 978-1-83962-793-4 eBook (PDF) ISBN 978-1-83962-831-3
